Sectoral Asset Management Inc Neurocrine Biosciences Inc Transaction History

Sectoral Asset Management Inc

$88.6 Million
Q2 2025

A detailed history of Sectoral Asset Management Inc transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Sectoral Asset Management Inc holds 2,960 shares of NBIX stock, worth $422,244. This represents 0.42% of its overall portfolio holdings.

Number of Shares

2,960

Previous 2,905 1.89%

Holding current value

$422,244

Previous $321,000 15.89%

% of portfolio

0.42%

Previous 0.36%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$87.54 - $128.18 $4,814 - $7,049	55 Added 1.89%	2,960 $372,000
Q1 2025 May 15, 2025	SELL	$107.22 - $153.29 $953,721 - $1.36 Million	-8,895 Reduced 75.38%	2,905 $321,000
Q4 2024 Feb 14, 2025	SELL	$111.62 - $139.44 $79,808 - $99,699	-715 Reduced 5.71%	11,800 $1.61 Million
Q3 2024 Nov 14, 2024	BUY	$114.58 - $153.15 $983,096 - $1.31 Million	8,580 Added 218.04%	12,515 $1.44 Million
Q2 2024 Aug 13, 2024	SELL	$130.86 - $143.19 $34,023 - $37,229	-260 Reduced 6.2%	3,935 $541,000
Q1 2024 May 14, 2024	SELL	$130.4 - $143.74 $32,600 - $35,935	-250 Reduced 5.62%	4,195 $578,000
Q4 2023 Feb 14, 2024	BUY	$106.07 - $132.76 $43,488 - $54,431	410 Added 10.16%	4,445 $585,000
Q3 2023 Nov 14, 2023	BUY	$94.02 - $117.1 $54,061 - $67,332	575 Added 16.62%	4,035 $453,000
Q2 2023 Aug 11, 2023	BUY	$89.53 - $104.87 $59,089 - $69,214	660 Added 23.57%	3,460 $326,000
Q4 2022 Feb 10, 2023	SELL	$106.72 - $127.06 $26,680 - $31,765	-250 Reduced 8.2%	2,800 $334,000
Q2 2022 Aug 15, 2022	BUY	$75.79 - $100.07 $231,159 - $305,213	3,050 New	3,050 $297,000
Q3 2020 Nov 13, 2020	SELL	$96.16 - $135.15 $1.36 Million - $1.91 Million	-14,100 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$85.09 - $130.36 $1.2 Million - $1.84 Million	14,100 New	14,100 $1.72 Million
Q4 2018 Feb 12, 2019	SELL	$68.32 - $124.36 $464,780 - $846,021	-6,803 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$98.88 - $125.85 $672,680 - $856,157	6,803 New	6,803 $836,000
Q2 2018 Aug 13, 2018	SELL	$75.3 - $105.99 $8.39 Million - $11.8 Million	-111,402 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$75.88 - $92.43 $2.34 Million - $2.86 Million	-30,900 Reduced 21.71%	111,402 $9.24 Million
Q4 2017 Feb 13, 2018	SELL	$58.53 - $77.59 $5.29 Million - $7.01 Million	-90,300 Reduced 38.82%	142,302 $11 Million
Q3 2017 Nov 14, 2017	BUY	$47.97 - $61.28 $11.2 Million - $14.3 Million	232,602	232,602 $14.3 Million

Others Institutions Holding NBIX

# of Institutions

663

Shares Held

102M

Call Options Held

290K

Put Options Held

214K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.6B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sectoral Asset Management Inc with notifications on news.

Account

Sectoral Asset Management Inc Neurocrine Biosciences Inc Transaction History